Lyophilisation for Pharmaceuticals: Products and Services 2014-2024

LONDON, February 18, 2014 /PRNewswire/ --

& Future Prospects for Leading Companies

Lyophilisation for pharmaceuticals  - discover trends and segments with highest revenue potential

What are the commercial prospects for pharmaceutical freeze-drying? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there.

Our new study lets you assess projected sales at world market, submarket and national level to 2024. You will see financial results, interviews, trends, opportunities, and revenue predictions. In our investigation you also see qualitative analyses, news, R&D and business developments. Also, you see qualitative analyses (SWOT, PESTEL and Porter's Five Forces).

Our 254 page report provides 143 tables, charts, and graphs. Read the full transcripts of three exclusive expert opinion interviews from leading industry specialists informing your understanding and allowing you to assess prospects for investments and sales:
- Dr. Davide Fissore, Professor of Advanced Process Control, Food Processing Technologies and Data Driven Modelling, Politecnico di Torino
- Dr. Tudor Arvinte, CEO, Therapeomic Inc and Professor at University of Geneva (Switzerland), Department of Pharmaceutics and Biopharmaceutics
- Dr. Matthew Brown, Development Scientist, Genzyme

You will find prospects for freeze drying submarkets and therapeutic applications

In addition to analyses of the overall world market, you will see revenue forecasting of four world-level submarkets to 2024:
• cGMP lyophilisers
• Laboratory lyophilisers
• Lyophilisation services
• Others

Also, you will see how nine drug classes using freeze drying technology will perform to 2024:
• Therapeutic monoclonal antibodies (mAbs)
• Insulins
• Erythropoietins
• Interferons
• G-CSF agents
• Recombinant coagulation factors
• Biosimilars
• Vaccines
• Other therapeutic proteins

Our investigation shows business research and analysis with individual revenue forecasts and discussions. Use our predictions to help expand your business and give you more influence. You will receive the forecasting leaders need.

To see an exec summary of this report please email Sara Peerun on sara.peerun@visiongainglobal.com

What are the prospects in leading regions and countries?

There are many commercial opportunities for lyophilisation technology and services in developed and developing countries. Our investigation gives you multi-level business research and analysis with sales forecast. You see how the industry and market can perform from 2014 to 2024.

In our study you will find individual revenue forecasts to 2024 for 14 national markets:
•    US
•    Japan
•    Germany
•    France
•    Italy
•    Spain
•    UK
•    China
•    India
•    Russia
•    Brazil
•    Turkey
•    Mexico
•    South Korea
•    RoW

In particular, some Asia Pacific regions will show high growth. New biological drugs and vaccines will benefit regional and national markets for those pharmaceutical drying technologies.

Leading companies and potential for market growth

Overall world revenue for the lyophilisation market will reach $3.09bn in 2014, our work forecasts. We predict strong revenue growth from 2014 to 2024. Our work shows you what services and organisations hold greatest potential. See profiles of 7 leading companies, including these:
•    SP Scientific
•    GEA Pharma Systems
•    IlShinBioBase
•    Vetter Pharma-Fertigung
•    Labconco Corporation
•    Boehringer Ingelheim
•    IMA Life

In general, a company profile gives you the following information
•    Discussion of a company's activities and outlook
•    Recent financial results
•    Assessment of recent developments - mergers and acquisitions (M&A) and collaborations

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

To see an exec summary of this report please email Sara Peerun on sara.peerun@visiongainglobal.com

Prominent Issues affecting the industry and market

Our study lets you assess industry trends and outlooks. You will find discussions, including qualitative analyses:
•    Increasing demand for parenteral drugs
•    Growing markets for biopharmaceutical products
•    Preparation, protection and storage of labile and heat-sensitive drugs
•    Injectable solutions, therapeutic proteins, peptides, vaccines and other aspects of biopharmaceutical production
•    Emerging technologies such as controlled ice nucleation and novel PAT tools

You will see discussions of technological, commercial, and economic matters, with emphasis on organisations developing technologies and services.

How the  Lyophilisation for Pharmaceuticals: Products and Services 2014-2024 & Future Market Prospects for Leading Companies  report helps you

In summary, our 254 page report gives you the following knowledge:
•    Revenues forecasts to 2024 for the overall world market and 4 submarkets - discover the industry's prospects, finding promising places for investments and revenues
•    Assessment of 7 leading companies, and others, discovering activities and outlooks
•    Market forecasting to 2024 for 14 national markets - US, Japan, Germany, France, UK, Italy Spain, Brazil, Russia, India, China, Mexico, Turkey, South Korea and RoW
•    View opinions from our survey, seeing interviews with authorities
•    Investigation of competition and opportunities influencing sales
•    Discussion of what stimulates and restrains the industry and market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our survey you are less likely to fall behind in knowledge or miss opportunities. See there how you could benefit your research, analyses, and decisions. Also see how you can save time and get recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for lyophilisation for pharmaceuticals. You will find data, trends and predictions. Please order our report now.

To request an exec summary of this report please email Sara Peerun at            sara.peerun@visiongainglobal.com or call Tel : +44 (0) 20 7336 6100

Or click on http://www.visiongain.com/Report/1202/Lyophilisation-for-Pharmaceuticals-Products-and-Services-2014-2024

Companies Listed in this report:

AAIPharma Services
Abbott
ACMAS Technocracy
Aesculap Surgical
Affinity Life Sciences
Albany Molecular Research Inc. (AMRI)
ALCOR Scientific
ALK-Abello A/S (ALK)
Allergan
Althea Technologies
American Home Patient
Amgen
Arena Pharmaceuticals
ASME
Aspen
Astellas Pharma
Attends Healthcare Products
Bariatric Solutions
Baxter
Baxter BioPharma Solutions
Baxter International
Bayer
Bayer HealthCare Pharmaceuticals
Beijing Suyuan Zhongtian Scientific Inc.
Ben Venue Laboratories
Berna Biotech
Bilcare Global Clinical Supplies
Bilthoven Biologicals
Bio Sidus
Biogen Idec
Biolyph
Bio-Manguinhos/Fiocruz
BioPartners
Biopharma Process Systems
Biopharma Technology
Boehringer Ingelheim
Boehringer Ingelheim BioXcellence
Boehringer Ingelheim Contract Manufacturing
Boehringer Ingelheim KG
Boston Scientific
Braun Melsungen
C.R. Bard
Cangene bioPharma
Canyon
Cardinal Health
Catalent Pharma Solutions
Centocor Biotech, Inc
Centocor Ortho Biotech
Cephalon
Changzhou Yibu Drying Equipment Co.
Chemisch-Pharmazeutisches Laboratorium Ravensburg GmbH
China Association for Pharmaceutical Equipment
Ciba-Geigy
CIMA Labs
CMC Biologics
Coldstream Laboratories
Cole-Parmer Instrument Company
Coloplast
CONMED
ConvaTec
Cook Medical
Cook Pharmica
Corden Pharma
CoreRx Pharmaceuticals
Corixa
Cousin Biotech
Covidien
Creapharm
CSL Behring
CSL Biotherapies
CT Arzneimettel
Cuddon Freeze Dry
Dong-A-Pharm
DSM Pharmaceuticals
E.R. Squibb & Sons
Eli Lilly and Company
EMD Serono
EnteroMedics
EnWave Corporation
Eurogentec
European Freeze Dry
ev3 Corporate
Famar Health Care Services
Ferring Pharmaceuticals
First Quality Enterprises
Formatech
Freeze Dryer Systems Europe
Freeze Drying Solutions
Freeze Dry Specialties
Fresenius Kabi Product Partnering
Frozen In Time
FTS Systems
Fujifilm Diosynth Biotechnologies
Fujinon Endoscopy
Gate Pharmaceuticals
GE Healthcare
GEA Group
GEA Lyophil GmbH
GEA Niro
GEA Pharma Systems (GPS)
GEA Process Engineering
GEI International
Genentech
GeneScience
Genevac
Genzyme
Getz Pharma Research
GI Dynamics
GILYOS GmbH
GIPHARMA
Girindus
Given Imaging
Gland Pharma Limited
GlaxoSmithKline (GSK)
GlaxoSmithKline Biologicals
GP Pharm
Graham Partners
Grand River Aseptic Manufacturing
Gyrus ACMI
Haake Buhler Instruments
Haupt Pharma
Helioscopie
Hollister
HollisterStier Laboratories
Hosokawa Micron Powder Systems
Hospira
HTD Biosystems
Hull
Human Genome Sciences
I.M.A. Industria Macchine Automatiche
iBio
IDT Biologika
ilShin America
IlShin Engineering
ilShin Lab Co. Ltd
IlShinBioBase
IMA ACTIVE
IMA Group
IMA Life
IMA Life (Beijing) Pharmaceutical Systems Co., Ltd.
IMA Life Pharmaceutical Systems Co. Ltd
IMA Pharma
IMA SAFE
Immunex Corporation
Intas Biophrmaceuticals
Intelligent Pharma
Irvine Pharmaceutical Services
ISC ltd (Ilshin Corporation)
IShinBioBase
Janssen Cilag
JHP Pharmaceuticals
Johnson and Johnson (J&J)
Jubilant Life Sciences Company
Kadmon
Kao Corporation
Karl Storz
KBI Biopharma
Kimberly-Clark Corporation
KP Pharmaceutical Technology
Labconco Corporation
Laboratory Construction Company
Legacy Pharmaceuticals International
LG Life Sciences
LifeScientz Bio-tech Company
Linde
Lonza
Lumenis
Lyka Labs
Lyofal
Lyophilization Services of New England
Lyophilization Systems Inc.
Lyophilization Technology
Martin Chris
Martin Christ Gefriertrocknungsanlagen
MechaTech Systems
Medical Innovation Development Company
MedImmune
Merck & Company
Merck Serono
Merck Sharp & Dohme Corporation
Merk Process
Millrock Technology
Miltenyi Biotec
Ministry of Health
MLHW
Moog Inc.
Nanjing Guyan Pharmaceutical Equipment Co.
Nanolek
National-Hotpack.
Netherlands Vaccine Institute (NVI)
Nextar Chempharma Solutions
NextPharma Technologies
Novartis
Novartis Pharmaceuticals Corporation
Novartis Vaccines and Diagnostics
Novo Nordisk
NPS
Oakwood Laboratories
OctoPlus
One 2 One
ONTEX International
Optima Group Pharma
Optima Pharma
Oregon Freeze Dry
Orexigen Therapeutics
Organon Teknika Corporation
Oso BioPharmaceuticals Manufacturing
OST Medical
PARE Surgical
Patheon
Paul Hartmann
Pentax Medical
Peptisyntha
Pfizer
Pfizer CentreSource (PCS)
Pharmatek Laboratories
PharmIdea
Pigeon Corporation
Piramal Pharma Solutions
Praxair, Inc
ProJect Pharmaceutics
Pyramid Laboratories
Q Core Medical
Quorum Technologies
Recipharm
Recipharm Cobra Bio
Regeneron Pharmaceuticals
Reig Jofre Group
Richard Wolf
RK Medicare Private Limited
Roch Mechatronics
Roche
Roche group
Royal Society of Chemistry
SAFC
Salts Healthcare
Sandoz
Sanofi Pasteur
Satiety Inc.
Schering Corporation
Schering-Plough HealthCare
Schott
Serail
SGD Pharma
Shandong Weigao
Shanghai Far-East Pharmaceutical Machinery General Factory
Shanghai Findnovo Mechanical Technology Co.
Shanghai Medical Instrument Manufacturing Co.
Shanghai Pudong Freeze Dryer Equipment Co., Ltd.
Shanghai Suparnin Pharmaceutical Equipment Co., Ltd.
Shanghai Tofflon Science and Technology Co., Ltd.
Shanghai Yucheng Dryer Equipment Co.
SL Pharma Labs
Solvay Group
SP Industries, Inc
SP Scientific
SPI Pharmaceuticals
Spirus Medical
SterilMed
Stryker Corporation
Surgical IOC
Svenska Cellulosa Aktiebolaget
Swedish Orphan Biovitrum
Synthes
Talecris Biotherapeutics
Telstar
Teva
Therapeomic Inc.
Therapeutical Goods Administration (TGA)
Therapure Biopharma
Thermo Fisher Scientific
Union Chimique Belge (UCB)
Uni-Charm Corporation
Unilife Corporation
USIFROID
Valeant Pharmaceuticals International
Vetter Pharma International GmbH (VPI)
Vetter Pharma-Fertigung
Vetter Pharma-Fertigung GmbH & Co. KG
Vidara
VirTis
Vivus
Welch Allyn
West Pharmaceutical Services
Wheaton Science Products
Wilmad-LabGlass
Wockhardt
Wyeth Pharmaceuticals Company
Xellia Pharmaceuticals
Zhangjiang Biotech & Pharmaceutical Base Development Company
Zirbus Technology
Z-SC1 Company

Other Organisations Mentioned in This Report

Agência Nacional de Vigilância Sanitária (National Health Surveillance Agency Brazil) (ANVISA)
Central Drug Standard Control Organisation (CDSCO)
Cornell University
Deutsches Institut für Normung  (DIN)
Drug Administration (DGDA)
European Commission
European Medicines Agency (EMA)
Global Harmonisation Task Force (GHTF)
Harvard Medical School
Health Canada
Health Maintenance Organisations (HMOs)
International Conference on Harmonization (ICH)
International Organization for Standardization (ISO)
Korea Food & Drug Administration (KFDA)
Max-Planck-Institute, C.N R.S.
Medicines and Healthcare products Regulatory Agency (MHRA)
Medicines Control Council (MCC)
National Agency for Food and Drug Administration and Control (NAFDAC)
Politecnico di Torino
Purdue University
Research Foundation for Microbial Diseases of Osaka University
Texas A&M University
The European Commission
The European Union's GMP (EU-GMP)
The Russian Government
The University of Connecticut
The University of Iowa Pharmaceuticals
University College London
University of Düsseldorf
US Code of Federal Regulations
US Endoscopy
US Food and Drug Administration (FDA)
World Federation Guidelines for Microorganisms
World Health Organization (WHO)

To see an exec summary of this report please email Sara Peerun on sara.peerun@visiongainglobal.com